Xeno Transplants Corporation

Xeno Transplants Corporation

XENO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.04K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Xeno Transplants CorporationXeno Transplants Corporation0--1525%-14.4

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4,036.00
Enterprise Value$484,449.00
Earnings per Share$0
Beta-0.2
Outstanding Shares40,363,822

Return

Return on Equity-1525.13%ROE
Return on Assets-47.04%
Return on Invested Capital-1525.13%

Valuation & Multiples

P/E Ratio-0.03P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.95
Enterprise Value to Net Income-1
Total Debt to Enterprise0.99
Debt to Equity14.44Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Xeno Transplants Corporation

0
CEO: Elliot Lebowitz

Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, an...